Hyperfine, Inc. (HYPR)
0.761
-0.04
(-4.89%)
USD |
NASDAQ |
Oct 15, 14:56
Hyperfine Gross Profit Margin (Quarterly) : 50.72% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.72% |
| March 31, 2026 | 50.70% |
| December 31, 2025 | 50.90% |
| September 30, 2025 | 53.77% |
| June 30, 2025 | 49.26% |
| March 31, 2025 | 41.32% |
| December 31, 2024 | 35.59% |
| September 30, 2024 | 52.37% |
| June 30, 2024 | 49.66% |
| March 31, 2024 | 41.09% |
| December 31, 2023 | 38.50% |
| September 30, 2023 | 48.24% |
| Date | Value |
|---|---|
| June 30, 2023 | 42.71% |
| March 31, 2023 | 43.83% |
| December 31, 2022 | 21.07% |
| September 30, 2022 | 29.30% |
| June 30, 2022 | -10.76% |
| March 31, 2022 | 5.57% |
| December 31, 2021 | -103.9% |
| September 30, 2021 | -91.11% |
| June 30, 2021 | -27.65% |
| March 31, 2021 | -83.69% |
| December 31, 2020 | -94.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.1% |
| Return on Assets | -65.67% |
| Return on Invested Capital | -86.42% |
| Profit Margin (Quarterly) | -238.2% |
| Operating Margin (Quarterly) | -216.9% |
| Return on Net Operating Assets | -214.8% |